Seifoleslami Mehri
Department of Gynecology, Khanevadeh Hospital, AJA University of Medical Sciences, Tehran, Iran.
Interv Med Appl Sci. 2017 Dec;9(4):204-207. doi: 10.1556/1646.9.2017.37.
Thrombocytopenia occurs to approximately 8%-10% of pregnant women and this condition is a notable source of morbidity and mortality during pregnancy. In the recent years, our comprehension of thrombocytopenia has progressed on pregnancy. Nevertheless, there has not been adequate information about thrombocytopenia outcomes in obstetric patients. With regard to this topic, we reviewed published reports as an update from the managements on these cases. Nevertheless, recommendations for management of delivery in obstetric women with thrombocytopenia are based on several hypotheses requiring critical analysis. For this cause, we reviewed the management of pregnant patients with thrombocytopenia treated over a period of 37 years.
约8%-10%的孕妇会出现血小板减少症,这种情况是孕期发病和死亡的一个显著原因。近年来,我们对孕期血小板减少症的认识有所进展。然而,关于产科患者血小板减少症的预后尚无足够信息。关于这一主题,我们回顾了已发表的报告,作为这些病例管理的最新情况。然而,对血小板减少症产科妇女分娩管理的建议基于若干需要批判性分析的假设。因此,我们回顾了37年来对血小板减少症孕妇的治疗管理情况。